Treatment of Mediterranean visceral leishmaniasis - PubMed (original) (raw)

Clinical Trial

Treatment of Mediterranean visceral leishmaniasis

L Gradoni et al. Bull World Health Organ. 1995.

Abstract

Up-to-date information is given on the epidemiological situation of zoonotic visceral leishmaniasis (ZVL) in nine Mediterranean countries, and on drug regimens adopted in the management of ZVL patients in each country. Results of experimental and clinical trials on the efficacy and tolerability of liposomal amphotericin B in laboratory animals and in patients with ZVL are presented, as well as conclusions and recommendations on drug regimens to be used in the treatment of ZVL.

PubMed Disclaimer

References

    1. Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):477 - PubMed
    1. Lancet. 1992 Jun 6;339(8806):1427 - PubMed
    1. Epidemiol Infect. 1993 Oct;111(2):297-306 - PubMed
    1. Lancet. 1991 May 4;337(8749):1061-2 - PubMed
    1. Trans R Soc Trop Med Hyg. 1993 May-Jun;87(3):310 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources